Citigroup Inc Beyond Spring Inc. Transaction History

Citigroup Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$1.06 - $1.81 $784 - $1,339	-740 Reduced 9.79%	6,815 $7,000
Q2 2022 Aug 10, 2022	SELL	$1.13 - $2.66 $75 - $178	-67 Reduced 0.88%	7,555 $11,000
Q1 2022 May 12, 2022	BUY	$1.68 - $5.01 $3,533 - $10,536	2,103 Added 38.1%	7,622 $17,000
Q4 2021 Feb 10, 2022	BUY	$4.02 - $16.84 $11,911 - $49,896	2,963 Added 115.92%	5,519 $25,000
Q3 2021 Nov 10, 2021	BUY	$9.26 - $31.31 $23,668 - $80,028	2,556 New	2,556 $40,000

5.44M

30.3K

1.8K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $95.4M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.